Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Soligenix Closes Patient Enrollment In orBec Phase 2 Trial
The Phase 2 trial enrolled 140 patients who have been randomised to either orBec or placebo at a 2:1 ratio. The primary endpoint of this trial is the
The Phase 2 trial enrolled 140 patients who have been randomised to either orBec or placebo at a 2:1 ratio. The primary endpoint of this trial is the
Vical said that the Phase 2 trial was a single-arm, open-label study in which 127 chemo-refractory or chemo-intolerant patients subjects were treated with high-dose Allovectin-7. The median age
In a share exchange transaction Virtual Closet has acquired control of Dong Ke Pharmaceutical, the parent company of Yangling Slovan Pharmaceuticals, a wholly foreign-owned enterprise organized under the
Novus Biologicals said that this new kit allows researchers to use any antibody, regardless of the buffer or concentration, with Lightning Link Kits. Antibodies are sometimes only available
Aesica supplies active pharmaceutical ingredients, formulations and custom synthesis products to pharmaceutical and biotechnology industries. It was formed in 2004 after a management buy-out of the former BASF
Reportedly, clinical trials have demonstrated that Stem-Kine supplementation yields effects on circulating stem cell populations such as 50-90% increase in CD34+ and CD133+ stem cells, peaking between 2
The FDA has received reports of serious side effects in people who have mistakenly swallowed the product. Some OTC Benadryl products are intended to be swallowed. However, Benadryl
PLx Pharma claimed that the other grants NIH has awarded to it in the recent months include The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Prior to joining GSK in 2006, Patrick was a clinical academic and led the division of medicine at UCL. He has over 20 years of experience of clinical
CG400549 is a potential antibiotic candidate targeting ENR (Enoyl-acyl carrier protein reductase, which is a critical enzyme in generating bacterial membrane) as it has novel chemical structure which